Literature DB >> 8876892

Laparoscopy: an important tool in the staging of malignant pleural mesothelioma.

K C Conlon1, V W Rusch, S Gillern.   

Abstract

BACKGROUND: The current standard for the noninvasive staging of patients with malignant pleural mesothelioma is computed tomography (CT). However, CT often cannot determine whether a tumor is unresectable because of direct extension through the diaphragm to the peritoneal cavity. The aim of this prospective study was to determine whether laparoscopy detected transdiaphragmatic tumor extension when CT findings were equivocal.
METHODS: From June 1993 to July 1994, 12 of 36 patients considered for possible thoracotomy and surgical resection had equivocal CT findings of diaphragmatic invasion. All underwent laparoscopy using a multiport technique with diaphragmatic and peritoneal biopsies.
RESULTS: The mean operative time was 83 min. There were no perioperative complications. The median hospital stay was 1 day. Six patients had biopsy-proven transdiaphragmatic extension, or peritoneal studding of tumor. The other six patients subsequently underwent thoracotomy: three had a complete resection, and three had unresectable tumor due to chest wall (N = 2) or mediastinal (N = 1) invasion. In no case was transdiaphragmatic extension of a tumor seen.
CONCLUSIONS: This preliminary experience demonstrates that laparoscopy is a safe and accurate method for detecting transdiaphragmatic tumor extension when CT fails to do so. Laparoscopy should be considered a standard part of prethoracotomy staging in this subset of patients.

Entities:  

Mesh:

Year:  1996        PMID: 8876892     DOI: 10.1007/bf02305768

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  22 in total

1.  The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.

Authors:  V W Rusch; S Piantadosi; E C Holmes
Journal:  J Thorac Cardiovasc Surg       Date:  1991-07       Impact factor: 5.209

Review 2.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Deterioration in lung function following hemithorax irradiation for pleural mesothelioma.

Authors:  P Maasilta
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-03       Impact factor: 7.038

4.  Laparoscopy for pancreatic cancer: does it benefit the patient?

Authors:  A Cuschieri
Journal:  Eur J Surg Oncol       Date:  1988-02       Impact factor: 4.424

5.  Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma.

Authors:  C Boutin; J R Viallat; N Van Zandwijk; J T Douillard; J C Paillard; J C Guerin; P Mignot; J Migueres; F Varlet; A Jehan
Journal:  Cancer       Date:  1991-04-15       Impact factor: 6.860

Review 6.  Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy.

Authors:  K B Allen; L P Faber; W H Warren
Journal:  Chest Surg Clin N Am       Date:  1994-02

7.  Malignant pleural mesothelioma: CT manifestations in 50 cases.

Authors:  A Kawashima; H I Libshitz
Journal:  AJR Am J Roentgenol       Date:  1990-11       Impact factor: 3.959

8.  Surgical treatment of pleural mesothelioma.

Authors:  P M McCormack; F Nagasaki; B S Hilaris; N Martini
Journal:  J Thorac Cardiovasc Surg       Date:  1982-12       Impact factor: 5.209

9.  MR imaging of malignant pleural mesothelioma.

Authors:  J G Lorigan; H I Libshitz
Journal:  J Comput Assist Tomogr       Date:  1989 Jul-Aug       Impact factor: 1.826

10.  Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.

Authors:  D J Sugarbaker; G M Strauss; T J Lynch; W Richards; S J Mentzer; T H Lee; J M Corson; K H Antman
Journal:  J Clin Oncol       Date:  1993-06       Impact factor: 44.544

View more
  6 in total

1.  Giant cystic lymphangioma of the liver.

Authors:  Liang Huang; Jing Li; Feiguo Zhou; Jianjun Yan; Caifeng Liu; Anli Yue Zhou; Albert Tang; Yiqun Yan
Journal:  Hepatol Int       Date:  2010-10-10       Impact factor: 6.047

2.  Extrapleural pneumonectomy and extended pleurectomy/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach.

Authors:  Valerie W Rusch
Journal:  Ann Cardiothorac Surg       Date:  2012-11

Review 3.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

4.  Hepatic lymphangioma: a rare cause of abdominal pain in a 30-year-old female.

Authors:  H Stunell; P F Ridgway; W C Torreggiani; P Crotty; K C Conlon
Journal:  Ir J Med Sci       Date:  2007-10-23       Impact factor: 1.568

Review 5.  Malignant mesothelioma: current status and perspective in Japan and the world.

Authors:  Seiki Hasegawa; Fumihiro Tanaka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-07-08

6.  Solitary hepatic lymphangioma: a one-case report.

Authors:  Qu Liu; Cheng-Jun Sui; Bao-Shan Li; Ang Gao; Jian-Yue Lu; Jia-Mei Yang
Journal:  Springerplus       Date:  2014-06-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.